T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus: Liver cell destruction by H-2 class i-restricted virus-specific cytotoxic t cells as a physiological correlate of the 51cr-release assay?

Journal of Experimental Medicine

Volumn 164, Issue 4, 1986, Pages 1075-1092

  Zinkernagel, Rolf M ^a   Haenseler, Edi ^a   Leist, Thomas ^a   Cerny, Andreas ^a   Hengartner, Hans ^a   Althage, Alana ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHROMIUM 51; GLUTAMATE DEHYDROGENASE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; CYTOTOXIC T LYMPHOCYTE; H2 SYSTEM; HEPATITIS; LIVER; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CHROMIUM RADIOISOTOPES; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; GLUTAMATE DEHYDROGENASE; H-2 ANTIGENS; HEPATITIS B; HEPATITIS, VIRAL, ANIMAL; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN M; LIVER; LYMPHOCYTIC CHORIOMENINGITIS; MALE; MICE; MICE, INBRED STRAINS; SPECIES SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0022530364     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.164.4.1075     Document Type: Article

References (50)

1. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1.
2. Hotchin, J. 1971. Persistent and slow virus infection. Monogr. Virol. 3:1.
3. Cole, G. A., N. Nathanson, and R. A. Prendergast. 1972. Requirement for φ-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (Lond.). 238:335.
4. Doherty, P. C., and R. M. Zinkernagel. 1974. T cell-mediated immunopathology in viral infections. Transplant. Rev. 19:89.
5. Zinkernagel, R. M., C.J. Pfau, H. Hengartner, and A. Althage. 1985. A model for MHC-disease associations: susceptibility to murine lymphocytic choriomeningitis maps to class I MHC genes and correlates with LCMV-specific cytotoxic T cell-activity. Nature (Lond.). 316:814.
6. Tosolini, F. A., and C. A. Mims. 1971. Effect of murine strain and viral strain on the pathogenesis of lymphocytic choriomeningitis infection and a study of footpad responses. J Infect. Dis. 123:134.
7. Hotchin, J., W. Kinch, and L. Benson. 1971. Lytic and turbid plaque-type mutants of lymphocytic choriomeningitis virus as a cause of neurological disease or persistent infection. Infect. Immun. 4:281.
8. Bro-J0rgensen, K. 1978. The interplay between lymphocytic choriomeningitis virus, immune function and hemopoiesis in mice. Adv. Virus Res. 22:327.
9. Wilsnack, R. W., and W. P. Rowe. 1964. Immunofluorescent studies of the histo-pathogenesis of lymphocytic choriomeningitis virus infection. J Exp. Med. 120:829.
10. Hoffsten, P. E., M. B. A. Oldstone, and F.J. Dixon. 1977. Immunopathology of adoptive immunization in mice chronically infected with lymphocytic choriomeningitis virus. Clin. Immunol. Immunopathol. 7:44.
11. Vyas, G. N., J. L. Dienstag, and J. H. Hoofnagel, editors. 1984. Viral Hepatitis and Liver Disease. Grune and Stratton, Inc. 728.
12. Bianchi, L. 1981. The immunopathology of acute type B hepatitis. Springer Semin. Immunopathol. 3:421.
13. Mondelli, M., and A. L. W. F. Eddleston. 1984. Mechanisms of liver cell injury in acute and chronic hepatitis B. Semin. Liver Dis. 4:47.
14. Buchmeier, M. J., R. M. Welsh, F. J. Dutko, and M. B. A. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275.
15. Cerny, A., A. W. Hiigin, S. Sutter, Ch. H. Heusser, N. Bos, S. Izui, H. Hengartner, and R. M. Zinkernagel. 1985. Suppression of B cell development and antibody responses in mice with polyclonal rabbit and monoclonal rat anti-IgM antibodies. Exp. Cell Biol. 53:301.
16. Bergmeyer, H. U., and M. Horder. 1980. IFCC Methods for the measurement of katalytic concentrations of enzymes. Clin. Chim. Acta. 105:147.
17. Bergmeyer, H. U., P. Scheibe, A. W. Wahlefeld. 1978. Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin. Chem. 24:58.
18. Anonymous. 1970. Empfehlung der Deutschen Gesellschaft fur Klinische Chemie. Standardisierung von Methoden zur Bestimmung von Enzymaktivitaten in biolo-gischen Fliissigkeiten. Z. Klin. Chem. Klin. Biochem. 8:658.
19. Bowers, G. N., and R. B. McComb. 1975. Measurement of total alkaline phosphatase activity in human serum. Clin. Chem. 21:1988.
20. Zinkernagel, R. M., and P. C. Doherty. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restrictions-specificity, function and responsiveness. Adv. Immunol. 27:51.
21. Cerottini, J.-C., and K. T. Brunner. 1974. Cell-mediated cytotoxicity, allograft rejection and tumor immunity. Adv. Immunol. 18:67.
22. Marshak-Rothstein, A., P. Fink, Th. Gridley, D. H. Raulet, M. J. Bevan, and M. L. Gefter. 1979. Properties and application of monoclonal antibodies directed against determinants of the Thy 1 locus. J Immunol. 122:2491.
23. Gottlieb, P. D., A. Marshak-Rothstein, K. Auditore-Hargreaves, D. B. Berkoben, D. A. August, R. M. Rosche, and J. D. Benedetto. 1980. Construction and properties of new Lyt-congenic strains and anti-Lyt 2.2 and anti-Lyt 3.1 monoclonal antibodies. Immunogenetics. 10:545.
24. Ceredig, R., D. P. Dialynas, F. W. Fitch, and H. R. MacDonald. 1983. Precursors of T cell growth factor producing cells in the thymus: Ontogeny, frequency, and quantitative recovery in a subpopulation of phenotypically mature thymocytes defined by monoclonal antibody. J Exp. Med. 158:1654.
25. Zinkernagel, R. M., T. Sado, A. Althage, and H. Kamisaku. 1984. Anti-viral immune response of allogeneic irradiation bone marrow chimeras: cytotoxic T cell responsiveness depends upon H-2 combination and infectious agent. Eur. J. Immunol. 14:14.
26. Julius, M. H., E. Simpson, and L. A. Herzenberg. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:645.
27. Oldstone, M. B. A., N. Y. Sinha, P. Blount, A. Tishon, M. Rodriguez, R. Von Wedel, and P. W. Lampert. 1982. Virus-induced alterations in homeostasis: alterations in differentiated functions of infected cells in vivo. Science (Wash. DC). 218:1125.
28. Baenziger, J., H. Hengartner, R. M. Zinkernagel, and G. A. Cole. 1986. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur. J. Immunol. 16:387.
29. Blanden, R. V. 1974. T cell-response to viral and bacterial infection. Transplant. Rev. 19:56.
30. Wege, H., S. Sidell, and V. TerMeulen. 1982. The biology and pathogenesis of coronaviruses. Curr. Top. Microbiol. Immunol. 99:131.
31. Davis, B. D., R. Dulbecco, H. N. Eisen, and H. S. Ginsberg. 1980. Microbiology, third edition. Harper and Row, Hagerstown, MD. 1223.
32. Lee, A. K. Y., H. M. H. Ip, and V. C. W. Wong. 1978. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect. Dis. 138:668.
33. Dudley, F. J., R. A. Fox, and S. Sherlock. 1972. Cellular immunity and hepatitis-associated Australia antigen liver disease. Lancet. i:723.
34. Dienstag, J. L., S. M. Feinstone, R. H. Purcell.J. H. Hoofnagel, L. F. Barker, W. T. London, H. Popper, J. M. Petersen, and A. Z. Kapikian. 1975. Experimental infection of chimpanzees with hepatitis A virus. J Infect. Dis. 132:532.
35. Popper, H. 1982. Hepatocellular degeneration and death. In The Liver: Biology and Pathobiology. I. Arias, H. Popper, D. Schachter, and O. A. Shafritz. Raven Press, New York. 771-784.
36. Frosner, G. G., H. Schomerus, K. H. Wiedemann, R. Zachoval, B. Bayerl, U. Backer, G. A. Gathof, and U. Sugg. 1982. Diagnostic significance of quantitative determination of hepatitis B surface antigen in acute and chronic hepatitis B infection. Eur. J. Clin. Microbiol. 1:52.
37. Joller-Jemelka, H. I., H. F. Pfister, and P.J. Grob. 1985. Die prognostische Bedeutung der quantitativen HBsAG Bestimmungen bei akuter Hepatitis B. Schweiz. Med. Wochenschr. 115:1249.
38. Eddleston, A. L. W. F., and R. Williams. 1978. HLA and liver disease. Br. Med. Bull. 34:295.
39. Scullard, G. H., C. I. Smith, T. C. Merigan, W. S. Robinson, and P. B. Gregory. 1981. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology. 81:987.
40. Hoofnagel, J. H., G. M. Dusheiko, D. F. Schafer, E. A.Jones, K. C. Micetich, R. C. Young, and J. Costa. 1982. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann. Intern. Med. 96:447.
41. Kohler, H. S., J. Trembath, D. A. Merrill, J. W. Singleton, and R. S. Dubois. 1974. Immunotherapy with antibody, lymphocytes and transfer factor in chronic hepatitis B. Clin. Immunol. Immunopathol. 2:465.
42. Mondelli, M., G. M. Vergani, A. Alberti, D. Vergani, B. Portmann, A. L. W. F. Eddleston, and G. Williams. 1982. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: Evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol. 129:2773.
43. Townsend, A. R. M., and A. J. McMichael. 1984. The specificity of cytotoxic T lymphocytes stimulated with influenza virus; studies in mice and humans. Progr. Allergy. 36:10.
44. Vielh, Ph., and M. Castellazzi. 1985. Use of a P815-derived line with an amplified adenosine deaminase gene: an improved target for cellular cytotoxicity. Eur. J. Immunol. 15:981.
45. Henney, C. S. 1971. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells. J Immunol. 107:1558.
46. Miller, R. G., and M. Dunkley. 1974. Quantitative analysis of the 51Cr-release cytotoxicity assay for cytotoxic lymphocytes. Cell. Immunol. 14:284.
47. Zinkernagel, R. M., and P. C. Doherty. 1974. Characteristics of the interaction in vitro between cytotoxic thymus derived lymphocytes and target monolayers infected with lymphocytic choriomeningitis virus. Scand. J. Immunol. 3:287.
48. Lin, Y. L., and B. A. Askonas. 1981. Biological properties of an influenza A virus specific killer T cell clone: inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions. J Exp. Med. 154:225.
49. Byrne, J. A., and M. B. A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol. 51:682.
50. Engers, H. D., T. Lahaye, G. D. Sorenson, A. L. Glaserbrook, C. Horvath, and K. T. Brunner. 1984. Functional activity in vivo of effector T cell populations. II. Antitumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones. J. Immunol. 133:1664.